In a retrospective analysis, patients with colon cancer taking GLP-1 agonists had a 62% lower risk of 5-year mortality ...

The study found that the five-year mortality rate was significantly lower among patients who were using GLP-1 receptor ...

Patients with colon cancer using GLP-1 receptor agonists (the class of drugs behind treatments like Ozempic, Wegovy, and ...

GLP-1 receptor agonists like Ozempic and Wegovy may increase survival among patients with colon cancer. | Drug Discovery And ...

Survival rates also varied significantly by stage. In the combined analysis for men and women without metastasis, the ...

People with colon cancer who took GLP-1 drugs were less likely to die within 5 years than people not on GLP-1s, a new study ...

GLP-1 receptors - the drugs behind Ozempic and Mounjaro - could have great benefits for colon cancer patients, the study ...

Don’t wait for the first symptom. Start regular colorectal cancer screening at 45 years old to stay proactive about your ...

A new report says too few eligible Americans are being checked for the country’s deadliest cancer before it spreads.

The five-year survival rate for male and female patients in Japan who were diagnosed with pancreatic cancer between 2012 and 2015 came to 10.7 pct and 10.2 pct, respectively, the lowest among all ...

Colon cancer, also known as colorectal cancer, is one of the most frequent and aggressive cancers. According to the WHO, it ...

The FDA has approved a groundbreaking blood test for colon cancer screening, offering a less invasive and more accessible ...